Apollo Cancer Centres launches Shield™ Multi-Cancer Detection, a blood-based test that can detect signs of multiple cancers ...

Five hospitals in England and Wales have switched to urine test, rather than invasive hospital procedure ...

Merck (NYSE:MRK) reported positive Phase 3 results for tulisokibart, an anti-TL1A monoclonal antibody in moderate-to-severe ...

Nearly four in 10 women were initially told they had a UTI before later being diagnosed with bladder cancer. The post Bladder ...

Zydus and Apollo Hospitals collaborate to enhance access to a multi-cancer blood test for early detection in India.

The guidelines state that a test must be FDA-approved, personalized, tumor-informed, multiplex, and use PCR-NGS for ctDNA.

Unlike conventional screening methods that typically target a single cancer, Shield MCD is designed to detect signals ...

India launches a single blood test screening for 10 cancers, improving early detection while complementing - not replacing - ...

Zydus Lifesciences Ltd. has entered into an exclusive agreement with precision oncology company Guardant Health to introduce ...

Apollo Cancer Centres has partnered with Zydus Lifesciences to introduce Guardant Health's Shield Multi-Cancer Detection ...

Bladder cancer is often mistaken for UTIs with a urologist outliningg a list of 'painless' symptoms you should never ignore.

NHS hospitals across England and Wales are adopting a new at-home bladder cancer test that doctors say is more accurate, less invasive, and faster than current hospital procedures. Harry Maguire's ...